Mar 4, 2019 – ACS Omega
Abstract
In recent years, the development of ultrasound contrast agents has encouraged their use as a drug system for diagnosis and therapy. In this paper, polylactic acid (PLA) composite microbubbles (FA/DOX/GO/DOX/PLA) were prepared with graphene oxide (GO) as a carrier of the targeted factor folic acid (FA) and doxorubicin (DOX) by the multiple emulsification–solvent evaporating process. Appearance, particle size, and zeta potential of PLA composite microbubbles were characterized by using a nanoparticle size analyzer and transmission electron microscopy. Breast cancer cells MCF-7 were used to evaluate the antitumor activity of PLA composite microbubbles in vitro by using the CCK-8 and acridine orange staining method. The ultrasonic imaging effect of PLA composite microbubbles was investigated in New Zealand white rabbits by the Doppler color ultrasound imaging system. With Kunming mice as the research model, the acute toxicity of PLA composite microbubbles was examined. The experimental results showed that the prepared PLA composite microbubbles presented a hollow and spherical shape with a particle size of 600 nm or so and a zeta potential of −37.5 ± 10.0 mV. They had a good effect of the enhancing imaging, and clear ultrasound imaging can be obtained. PLA composite microbubbles showed a significant proliferation inhibition effect on breast cancer cells MCF-7 in a dose-dependent manner. After PLA composite microbubbles were modified by FA, they were good for targeting FA receptors on the surface of MCF-7 cells, which increased the inhibition rate of the tumor cells. LD50 of PLA composite microbubbles was 87.529 mg·kg–1; the mice did not show the acute toxicity when the dose of composite microbubbles was lower than this value.
Authors: Jie Zhang*† , Limei Song†, Huiming Zhang‡, Shujing Zhou*, Yufeng Jiao†, Xiangyu Zhang†, Yue Zhao†, and Ying Wang†
†School of Pharmacy and ‡School of Basic Medicine, Jiamusi University, Jiamusi 154007, China
ACS Omega, 2019, 4 (3), pp 4691–4696 DOI: 10.1021/acsomega.8b03403
Copyright © 2019 American Chemical Society
*E-mail: zjie612@163.com (J.Z.)., *E-mail: zhshj2003@163.com (S.Z.).
